Stock Market Watch

J&J Recalling Benadryl and Motrin

by ·

Johnson & Johnson (NYSE:JNJ) is recalling two of its popular drugs from the market citing insufficiencies in the manufacturing process. The recall is being made for more than 4 million packages of junior strength Motrin and children’s Benadryl Allergy tablets.

The recall is only for the current stock which has only reached wholesalers and retailers. Hence the customers who have the medicine already purchased a week before can safely use them. The recalled medicines do not have any heath safety concerns. There was no immediate effect on the shares of Johnson & Johnson (NYSE:JNJ) due to these recalls.

Related posts:

  1. Finding The Source of HIV
  2. Theraputic Discovery Grant Awarded to Affymax
  3. GSK Gets Green Light For Lupus
  4. Wal-Mart’s Success with Prescription Plan
  5. Jane Fonda Confirms breast Cancer



Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...